维普中文期刊产品整合服务
22篇 您的检索式:作者名="Chappell SL"
    题名 作者 年代 出处 被引量
1Very lowdensity lipoproteins stimulate surfactant lipid synthesis in vitro显示文摘Mallampalli RK Salome RG Bowen SL Chappell DA 1997J Clin Invest1997,99,8:1
2Role of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘Steelman LS Chappell WH Abrams SL 2011Aging (Albany NY)2011,3,3:1
3'targeting the cancer initiating cell:the Achilles' heel of cancer 显示文摘Mccubrey J A Chappell WH Abrams SL 2011Adv Enzyme Regul2011,51,1:1
4Roles of the Raf/MEK/ ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy- implications for cancer and aging 显示文摘Steelman IS Chappell WH Abram SL 2011Aging2011,3,3:1
5Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/m TOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging显示文摘Steelman LS Chappell WH Abrams SL 2011Aging(Albany NY)2011,3,3:1
6Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘Steelman LS Chappell WH Abrams SL 2011Aging (Albany NY)2011,3,3:1
7Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘Steelman LS Chappell WH Abrams SL 2011Aging (Albany NY)2011,3,3:1
8Roles of the Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 显示文摘Steelman LS Chappell WH Abrams SL 2011Aging (Albany NY)2011,3,2:1
9Expression and regulation of RAB3 proteins in osteoclasts and their precursors显示文摘Abu-Amer Y Teitelbaum SL Chappel JC Schlesinger P Ross FP 0,,:1
10Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy- implica- tions for cancer and aging显示文摘Steelman LS Chappell WH Abrams SL 2011Aging: Albany NY2011,3,3:1
11Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion显示文摘Zhao H Ito Y Chappel J Andrews NW Teitelbaum SL Ross FP 0,,:1
12Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption显示文摘Ross FP Chappel J Alvarez JI Sander D Butler WT Farach-Carson MC Mintz KA Robey PG Teitelbaum SL Cheresh DA 0,,:1
13Vav3 regulates osteoclast function and bone mass显示文摘Faccio R Teitelbaum SL Fujikawa K Chappel J Zallone A Tybulewicz VL Ross FP Swat W 0,,:1
14Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization显示文摘Ito Y Teitelbaum SL Z ou W Z heng Y J ohnson J F Chappel J Ross FP Zhao H 0,,:1
15Roles of the Raf/MEK/ERK pathway in cel growth,malignant transformation and drug resistance显示文摘Mc Cubrey JA Steelman LS Chappell WH Abrams SL Wong EW Chang F 2007Biochim Biophys Acta2007,1773,8:1
16M-CSF regulates the cytoskeleton via recruitment of a multimeric signaling complex to c-Fms Tyr-559/697/721显示文摘Faccio R Takeshita S Colaianni G Chappel J Zallone A Teitelbaum SL Ross FP 0,,:1
17c-Src links a RANK/alphavbeta3 integrin complex to the osteoclast cytoskeleton显示文摘Izawa T Zou W Chappel JC Ashley JW Feng X Teitelbaum SL 0,,:1
18Roles of the Raf/MEK/ERK and PI3K/trl'EN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implica- tions for cancer and aging显示文摘Steelman LS Chappell WH Abrams SL 2011Aging (Albany NY)2011,3,3:1
19Targeting the RAF/MEK/ERK,PI3K/AKT and p53 pathways in hematopoietic drug resistance显示文摘Mc-Cubrey JA Steelman LS Franklin RA Abrams SL Chappell WH Wong EW 2007Adv Enzyme Regul2007,47,:1
20Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controllinggrowth and sensitivity to therapy-implications for cancer and aging显示文摘Steelman LS Chappell WH Abrams SL 2011Aging(Albany NY)2011,3,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费